Middle East In-Vitro Diagnostics Market is predicted to reach USD 3.48 Billion by 2030

According to the study by Next Move Strategy Consulting, the Middle East In-Vitro Diagnostics Market size is predicted to reach USD 3.48 billion, at a CAGR of 4.9% by 2030.

Request a FREE Sample: https://www.nextmsc.com/middle-east-in-vitro-diagnostics-market/request-sample

The increased investment in advancing Saudi Arabia's healthcare sector serves as a significant driver for the growth of the in-vitro diagnostics market in the country.

In Qatar, the in-vitro diagnostics industry is showing a significant growth due to the prevalence of various non-communicable diseases.

The promising players operating in the Middle East in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.